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A venovenous bypass for transplantation of the liver 
was developed and evaluated in dogs and applied clin-
ically, wlthfiows that averaged less than 500 milliliters 
p,er minute. Fatal pulmonary emboli were seen in two 
of 40 experiments. The venovenous flow in the four 
pediatric recijJients was 20() to 1,200 milliliters j)er 
minute, and there were nu cumplications. 
ALTHOUGH venovenous bypasses without sys-
temic heparinization have revolutionized adult 
hepatic transplantation, bypasses have not been 
used for pediatric recipients. Application of the 
technique has been inhibited by concern that 
clotting and consequent iatrogenic pulmonary 
emboli could occur in the low flow bypass circuits 
of small subjects. In this study, we report our 
experience with a low flow venovenous bypass 
that was acquired first witl} replacement of the 
liver in small dogs and subsequently with four 
pediatric hepatic recipients. 
METHODS 
Dogs. Orthotopic hepatic transplantation was 
performed upon 40 healthy beagle dogs weighing 
between 10 and 15 kilograms. General anesthesia 
was induced with 25 milligrams per kilogram 
thiopental sodium. The dogs were paralyzed with 
0.1 milligram per kilogram pancuronium bro-
mide and ventilated through a cuffed endotra-
cheal tube. 
Principles of the transplantation.-The ho-
mograft is cooled by infusing it with cold lactated 
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Ringer's solution as the donor is exsanguinated. 
The liver is placed into the fossa which is eva-
cuated by the recipient hepatectomy and it is 
revascularized with a modification of our origi-
nally described technique (1). The vena caval 
anastomoses above and below the liver are per-
formed as well as a portal venous anastomosis and 
an aorta to aorta anastomosis (Fig. 1). Recon-
struction of the biliary tract was done with cho-
lecystoduodenostomy after ligation of the graft 
common duct (Fig. 1). Transfusions usually are 
limited to the donor blood collected during ter-
minal exsanguination and hepatic cooling. 
The bypass.-The technique was similar to 
that described by Denmark and colleagues (2). 
The inferior vena caval system was drained 
through the proximal femoral vein after ligation 
of the distal vessel. Splenectomy was performed 
and the central splenic vein was cannulated to 
drain the splanchnic bed (Fig. 2). Venous re-
entry was through the external jugular vein (Fig. 
2). All of the cannulas were standard No. 12 chest 
tubes (Argyle Division of Sherwood Medical). 
The extracorporeal bypass consisted of a three-
eighth inch (internal diameter) Tygon (Norton 
Industrial Plastics) tubing interrupted with a 
centrifugal pump (Bio-Medicus, Inc.) and 
primed with 250 milliliters of Plasmalyte (Fig. 
2). An electromagnetic probe on the venous re-
turn side was used to measure flow. 
The venous bypass time was that req uired to 
complete the recipient hepatectomy, obtain he-
mostasis in the hepatic fossa and perform the ve-
nous anastomoses. Usually, the suprahepatic ca-
val, infrahepatic caval and portal anastomoses 
were carried out while on bypass before revascu-
larizing the portal vein. In a few dogs, the portal 
vein was revascularized after only the suprahe-
patic caval and portal anastomoses. Although this 
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TABLE I.-CLINICAL FEATURES OF PEDIATRIC HEPATIC RECIPIENTS 
Duration 
Age, Weight, bypass, 
OT*, No. yrs. kgm. Diagnosis rnlns. 
452 ..... 6 24 Drug induced acute liver failure 95 
478 ..... 5 15.5 Biliary atresia 130 
475 ..... 9 21 Familial intrahepatic cholestasis 108 
494 ..... 2Yz 13 Postnecrotic cirrhosis 232 
*OT, Orthotopic transplantation. 
modification reduced the cold ischemia time, it 
necessitated a period of even lower venovenous 
bypass flow since only the vena caval bed was 
being drained while the third anastomosis was 
performed. The aortic anastomosis was carried 
out after the bypass was terminated, after all 
cannulas had been removed and not until good 
hemostasis had been obtained. 
The human experience. Four children, each of 
whom had a different diagnosis, were two and 
one-half to nine years old and weighed between 
13 and 24 kilograms (Table I). The reasons for 
resorting to the venovenous bypasses are listed in 
Table 1. 
The equipment was the same as in the canine 
studies except that the chest tubes used for can-
nulas ranged from No. 12 to 16. When the chest 
tubes were inserted, they were flushed and filled 
with heparin diluted to 1/500, a precaution that 
was not exercised in dogs. The portal cannula 
was placed down the transected portal vein (3). 
The vena cava was decompressed through a can-
nula inserted at the saphenofemoral junction and 
venous return was to the axillary vein (3). Both 
the splanchnic and systemic venous systems were 
decompressed during most of the bypass, but 
during performance of the portal anastomosis, 
caval flow only was being bypassed. 
RESULTS 
In dogs. Bypass flow features.-In the 40 dogs 
(Table II), the flow range was 200 to 1,500 mil-
liliters per minute during the bypass periods of 
53.1±12.9 (S. D.) minutes, a range of 34 to 82. 
The average peak flow as 575.0±229.2 (S. D.) 
milliliters per minute. The mean minimum flow 
was 312.3±107.9 (S. D.) milliliters per minute, 
an average which was kept artifactually high by 
our policy of discontinuing bypasses when flows 
fell to less than 200 milliliters per minute. Such 
discontinuance near the end of the run was ne-
cessary in ten of the 40 experiments. 
The experiments were part of a program to 
evaluate the new cyclosporine analogue, Cyclo-
sporin G. Herein, it need only be noted that 80 
Caval plus Caval 
portal bypass 
bypass alone 
mf./min. ml./min. Reason for bypass 
1,000 600 Hypotension caused by venous occlusion 
1,200 400 to 200 Hepatectomy impossible otherwise 
1,200 600 Profound metabolic depletion. Hypotension 
caused by venous occlusion 
800 500 Profound metabolic depletion 
per cent of the test dogs survived the operation for 
at least six days postoperatively. If a bypass was 
maintained during the venous occlusions, the 
exact amount of flow did not obviously influence 
either survival or the rate of complications. 
Thromboembolic complications. The results of 
extensive clotting studies on six of the dogs were 
normal before and during the bypass. Two of the 
40 dogs died suddenly of pulmonary emboli. In 
both instances, the bypass was discontinued for 
several minutes because of technical problems. 
When pump-driven flow was resumed, clots in 
the stagnant blood in the tubing were advanced 
into the right atrium, right ventricle and pulmo-
nary artery. In two other experiments, fibrin 
strands were found in the pump head but these 
had not caused complications. When the same 
bypass system was tested under systemic hepa-
rinization of 3 milligrams per kilogram, the hep-
arin effect could not be reversed and the dogs bled 
to death. 
In humans. The bypass flows in the pediatric 
recipients ranged from 200 to 1,200 milliliters per 
minute (Table I). The lower flows always were 
at the end of the run when the portal anastomosis 
was being performed and when only vena caval 
blood was entering the bypass system. The dura-
tion of the bypasses was one and one-half to four 
hours (Table I). At their conclusion, fibrin or 
clots were not found in the extracorporeal cir-
cuits. The difficult technical or metabolic situa-
tions posed by these patients were dealt with eas-
ily, and all of the recipients are alive after one to 
four months. 
DISCUSSION 
The threat of pulmonary emboli from the ex-
tracorporeal circuit has been known since the first 
clinical trials of hepatic transplantation in which 
passive bypasses were used (4). The risk was well 
recognized by others (2, 3) who described pre-
cautions to prevent this complication. Other au-
thors have speculated that bypass flows of less 
than 1,000 milliliters per minute would be unsafe 
(5) . 
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FIG. 1. Completed orthotopic hepatic transplantation in 
dogs. G.b., Gallbladder; I.v.c., inferior vena cava; H.a., 
hepatic artery, and P.v., portal vein. 
In actuality, the safe level of flow is probably 
much lower than this. In the laboratory experi-
ment in which the dogs had normal clotting, 
bypass flows were almost always below 1,000 
milliliters per minute, and the average flow was 
less than one-half of this. Evidence of extra cor-
po rea I clot formation was uncommon, occurring 
in four of 40 dogs. 
Pulmonary emboli in two of these four dogs 
were precipitated by technical misadventures that 
caused nonflowing blood to be left stagnant in the 
extracorporeal circuit after which pumping was 
resumed. The pump presumably propelled the 
clots in these two dogs. 
In spite of the probable role of the pump in the 
embolization, the danger of thromboembolic 
complications has seemed to be less in the efficient 
pump driven circuits than it was with the passive 
bypasses that were used many years ago (4). To 
our knowledge, pump driven bypasses were first 
described in dogs (6). Others (6, 7) described a 
single pump driven femorojugular bypass after 
putting the splanchnic and systemic venous 
systems into communication with a temporary 
portacaval shunt (1). 
In the clinical situation, the risk of emboli 
should be substantially less than with normal 
dogs. Almost all hepatic recipients, including the 
four children reported upon herein, came to the 
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FIG. 2. Venovenous bypass used in dogs. Note entry of 
splanchnic cannula through the splenic vein after splenec-
tomy. s.v.c., Superior vena cava; I.v.c., inferior vena cava, 
and Ext. jug., external jugular vein. 
operating room with complex abnormalities of 
coagulation that are caused by end stage hepatic 
disease. In the four pediatric patients we studied, 
low flow bypasses were used for one and one-half 
to almost four hours without a trace of fibrin in 
the circuit. 
In the original report of Denmark and co-
authors (2), as in our laboratory and clinical ex-
perience reported herein, heparin bonded Gott 
shunts were not used. In one study (3), heparin 
bonded cannulas were added in the first clinical 
trials as a safety hedge. However, these cannulas 
TABLE H.-DATA FROM 40 VENOVENOUS BYPASSES 
IN DOGS UNDERGOING LIVER REPLACEMENT, 
PLUS OR MINUS VARIATIONS ARE STANDARD 
DEVIATION 
No. dogs .................................... . 
Mean weight, kgm ............................ . 
Mean maximum flow, ml./mins ................. . 
Mean minimum flow, ml./mins ................. . 
Bypass time, mins ............................. . 
40 
12.3±I.S 
S7S±229 
312±108 
S3±13 
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are expensive, bulky and often of inappropriate 
SIze. 
In 1984, chest tube cannulas of varying sizes 
were often used in adults as well as in children 
without any clotting difficulties. If this method is 
as good as with the heparin bonded cannulas and 
tubing, the expense of the venovenous bypasses 
will be substantially reduced. The question of 
need of the heparin bonded equipment remains to 
be resolved. 
SUMMARY 
A low flow venovenous bypass was used during 
the anhepatic phase of orthotopic transplantation 
of the liver in 40 dogs and in four pediatric reci-
pients who were two and one-half to nine years 
old and who weighed between 13 and 24 kilo-
grams. In these selected human recipients, the 
advantages of venovenous bypasses were the same 
as previously described for adults. 
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